Latest Episodes

Will the Biotech Rebound Run into Pricing Policy Obstacles?

The biotech industry is poised for an innovation-led rebound, but drug pricing is already in the election...

Read Time Read (2m) | View
Listen Time Listen (13m) | Apple Spotify

Few IPOs but plenty of follow-on for biotech in 2023

Biotech continues to bolster the healthcare market, but there are tailwinds for services and HCIT too, as...

Read Time Read (3m) | View
Listen Time Listen (23m) | Apple Spotify

Balancing Act: Biotech Juggles Innovation, Competition, Policy, and Funding

For biotech, innovation is a double-edged sword; competition in the biotech space remains high, with...

Read Time Read (4m) | View

Raising capital: A new playbook for a new era in biotech

In a market suppressed by inflation, how can the biotech industry continue to raise essential capital for...

Read Time Read (36m) | View

ECM: Robust End to Year, Despite Previous Volatility

As RBC Capital Markets looks forward to a robust end to the year, John Hoffman and Jason Levitz, Co-Heads of...

Read Time Read (4m) | View
Listen Time Listen (31m) | Apple Spotify

Biotech Halftime Report: A Winding Road Ahead

While competition and patent cliffs remain overhangs, innovation and regulatory permissiveness remain high...

Read Time Read (6m) | View
Listen Time Listen (17m) | Apple Spotify

When to Call it Quits: VCs Making Tough Decisions in a Tough Market

RBC’s Noël Brown, Head of US Biotechnology Investment Banking, recently held an Endpoints roundtable with...

Read Time Read (4m) | View
Listen Time Listen (32m) | Apple Spotify

A New Era of Healthcare Innovation

Healthcare and life sciences came out the other side of the pandemic more resilient and bursting with growth...

Read Time Read (4m) | View

Biotech M&A: Reshaping the Strategic Landscape

Biotech M&A remains a pivotal force in the ever-evolving world of biotech, forging strategic value and...

Read Time Read (4m) | View
Listen Time Listen (25m) | Apple Spotify

Key Takeaways from Our Global Healthcare Conference

Disruption, innovation and deal making have been focal points at our annual Global Healthcare conference for...

Read Time Read (3m) | View

Biotech M&A Booms, But Have We Reached A Tipping Point?

Gregory Renza, M.D., Senior Biotechnology Analyst, delves into the driving forces behind the recent surge of...

Read Time Read (4m) | View
Listen Time Listen (16m) | Apple Spotify

The Power and Potential of Genetic Medicine

Genetic medicine is poised to unlock more value for patients and investors. RBC’s biotechnology analyst Luca...

Read Time Read (3m) | View
Listen Time Listen (17m) | Apple Spotify

The Hidden Revolution Set to Turn US Healthcare on its Head

In this episode of Pathfinders, RBC’s Healthcare Technology Analyst Sean Dodge discusses the value-based...

Read Time Read (3m) | View
Listen Time Listen (19m) | Apple Spotify

The Big Picture for Biotech

In this latest episode, our head of biotech research Brian Abrahams shares a big picture analysis of the...

Read Time Read (3m) | View
Listen Time Listen (21m) | Apple Spotify

Why Biopharma Investment Requires a Different Mindset

In the latest episode of Pathfinders, Noël Brown, Head of US Biotechnology Investment Banking at RBC Capital...

Read Time Read (3m) | View
Listen Time Listen (22m) | Apple Spotify

The Optimism Behind the Biopharma Market

Dr. Chen Yu, Founder and Managing Partner at TCG X, discusses why he is optimistic about biotech, and what’s...

Read Time Read (3m) | View
Listen Time Listen (25m) | Apple Spotify

Biotech Investors: How to Find Value in a Bear Market

How are top investors navigating the longest biotech bear market in almost 20 years?

Read Time Read (5m) | View
Listen Time Listen (29m) | Apple Spotify

Serving the Underserved: Global Blood Therapeutics Commitment to Sickle-Cell Innovation

In this rebroadcast interview, Dr. Ted W. Love, President and CEO of Global Blood Therapeutics (GBT)...

Read Time Read (3m) | View
Listen Time Listen (27m) | Apple Spotify

Ionis: Raising the Bar for ESG

In this episode of Pathfinders, Luca Issi, Senior Biotech Analyst at RBC Capital Markets, speaks with Beth...

Read Time Read (3m) | View
Listen Time Listen (24m) | Apple Spotify

Biotech and Big Pharma: Blueprint for Successful Partnership

As biotech firms and large pharma companies find new synergies to bring new treatments to market together...

Read Time Read (5m) | View
Listen Time Listen (23m) | Apple Spotify

Inside Track: Behind the Scenes of a Major Biotech SPAC

RBC Capital Markets’ Noël Brown, Head of US Biotech Investment Banking, goes behind the scenes of one of the...

Read Time Read (4m) | View
Listen Time Listen (24m) | Apple Spotify

What’s Material in ESG for Biopharma Firms?

In this episode of Pathfinders, Brian Abrahams, Co-Head of Biotechnology Equity Research at RBC Capital...

Read Time Read (4m) | View
Listen Time Listen (18m) | Apple Spotify

Biotech SPACs: A New Route to Going Public

As more firms and investors look to SPACs as an IPO alternative, will this change the way biotech companies...

Read Time Read (4m) | View
Listen Time Listen (30m) | Apple Spotify

5AM Ventures: Fueling the Next Generation of Innovators

In this episode of Pathfinders, Brian Abrahams, Co-Head of Biotechnology Equity Research at RBC Capital...

Read Time Read (3m) | View
Listen Time Listen (19m) | Apple Spotify

Vida Ventures: Powering Breakthroughs in Biopharma

In this episode of Pathfinders, Luca Issi, Senior Biotech Analyst at RBC Capital Markets, speaks with Arjun...

Read Time Read (3m) | View
Listen Time Listen (23m) | Apple Spotify

Biotech IPOs: Navigating the New Landscape

Even in a boom, biopharma executives will need to stay alert to the risks of undertaking an IPO. Our...

Read Time Read (4m) | View
Listen Time Listen (20m) | Apple Spotify

Biotech IPOs: New Steps to Success on the Road to Going Public

In our launch edition of Pathfinders, our investment banking team looks at the best practices to follow on...

Read Time Read (3m) | View
Listen Time Listen (23m) | Apple Spotify

Pathfinders in Biopharma Podcast

Our podcast series explores the fast-moving world of biopharma and what the road ahead looks like for companies and investors in the sector.

Subscribe Now

More Healthcare insights

From biotech breakthroughs to digital transformation, our global healthcare specialists dive deep into the latest trends, innovations, and emerging opportunities.

Stay Informed

Get the latest insights from RBC Capital Markets delivered to your inbox.